Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors

NCT07743827 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Olanzapine
Breast Cancer
Dexamethasone

Interventions

DRUG: Pantoprazole
DRUG: olanzapine
DRUG: Dexamethasone

Sponsor

Alexandria University